Zydus Lifesciences Ltd. Financials

12:14 Jun 11

Zydus Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
982.90
+1.10 (+0.11%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Zydus Lifesciences Ltd. Financials

Zydus Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
982.90
+1.10 (+0.11%)
12:14 Jun 11
Quality
image/svg+xml

66/100
High Financial Strength

Valuation
image/svg+xml

46/100
Mid Valuation

Technical

50/100
Technically Neutral

Strength

11

Weakness

1

Opportunity

1

Threats

0

18.89 %

ROE %

12.16 %

ROA %

45.71

EPS

238.10

BVPS

19.47 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
14403.5 15265.2 17237.4 19547.4 23241.5
Operating Expenses +
11016.4 11924.5 13377.5 14163.1 16183
Raw Material
4958.3 5907.5 6072 6478.4 6522.9
Increase Decrease in Cost
-156.2 -362.3 238.1 -250.2 -184.9
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
2295.1 2434.1 2765.6 3137.6 3680.6
Miscellaneous Expenses
6497.8 7674.4 8200.6 8593.1 10464.4
Operating Profit
3387.1 3340.7 3859.9 5384.3 7058.5
Other Income
45.6 224.7 186.6 284.1 269.5
Depreciation
669.6 713 722.7 764.1 915.8
Interest
158.8 127 129.9 81.2 165.9
Profit before tax and exceptio..
2604.3 2725.4 3193.9 4823.1 6246.3
Exceptional Items
-205.1 112.7 -604.2 -14.2 -219.6
PBT
2399.2 2838.1 2589.7 4808.9 6026.7
Provision for Taxation
193.6 511.7 587.8 977.5 1411.9
Net Profit
2137.6 4572.1 1997.3 3854.4 4614.8
NET Profit after MI
2133.6 4487.3 1960.3 3859.5 4525.5
EPS
20.84 43.83 19.3 38.14 44.97
Operating Profit Margin (%)
23.52 21.88 22.39 27.54 30.37
Net Profit Margin (%)
14.81 29.4 11.37 19.74 19.47

Zydus Lifesciences Ltd. Shareholding

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 75.00 75.00 75.00 75.00 75.00
FII 7.30 7.50 7.50 5.60 5.70
MF 6.40 6.30 6.60 7.20 6.70
Others 4.60 4.40 4.10 5.40 5.90
Shareholder Shares Holding %
Download Our App On: